Clinical TrialsSearch results
Number of results: 643
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26
Other
- Allogeneic stem cell transplantation following reduced-intensity conditioning for relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- West Japan Hematology Oncology Group/ Hematological Malignancy Therapy Study Group/ Japan Study Group for Cell Therapy and Transplantation
- 2008-11-07
Recruiting
- Efficacy of Delgocitinib for Dermatomyositis
- Dermatomyositis
- Watanabe Tomoya
- 2023-05-16
Other
- ADOBARRIER study
- Rectal cancer
- Watanabe Jun
- 2020-10-15
Recruiting
- SPECTACLE study
- Rectal cancer
- Watanabe Jun
- 2023-07-10
Recruiting
- Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japan
- Esophageal cancer
- Watanabe Akinori
- 2021-04-01